Stay updated on Cobimetinib Combo vs. Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Cobimetinib Combo vs. Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cobimetinib Combo vs. Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    New revision entry added: v3.4.3, replacing the previous v3.4.2. This is a routine site version update without changes to the study data or record content.
    Difference
    0.1%
    Check dated 2026-03-12T02:46:14.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 to the history; removed the government-funding lapse notice and Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T14:19:24.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A government funding notice banner was added and the revision label updated from v3.4.0 to v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-04T10:29:47.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The history view adds a glossary toggle and color-coded highlights (green for additions, red for deletions) and updates the revision label to 'Revision: v3.4.0'; the No FEAR Act data note is updated accordingly.
    Difference
    0.7%
    Check dated 2026-01-28T06:25:47.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page footer now shows a new revision label (v3.3.4) replacing the previous v3.3.3. No core content or functionality appears to be affected.
    Difference
    0.1%
    Check dated 2026-01-14T01:58:16.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    The page footer shows a new revision tag v3.3.3 and removal of the HHS Vulnerability Disclosure and the previous revision v3.3.2. These are administrative footer updates that do not affect study details or navigation.
    Difference
    0.1%
    Check dated 2025-12-23T09:45:13.000Z thumbnail image

Stay in the know with updates to Cobimetinib Combo vs. Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cobimetinib Combo vs. Pembrolizumab in Melanoma Clinical Trial page.